Quality Clinical Research, Merz Investigational Site #0010522 — Omaha, Nebraska

Quality Clinical Research, Merz Investigational Site #0010522 is a clinical research site located in Omaha, Nebraska, United States 68114.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Quality Clinical Research, Merz Investigational Site #0010522 has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Chronic Migraine, Episodic Migraine.

Sponsors: Merz Therapeutics GmbH.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Quality Clinical Research, Merz Investigational Site #0010522?

Quality Clinical Research, Merz Investigational Site #0010522 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Quality Clinical Research, Merz Investigational Site #0010522 conducted?

Quality Clinical Research, Merz Investigational Site #0010522 has 2 clinical trials on record, with 2 currently active. Their work covers Chronic Migraine, Episodic Migraine.

Is Quality Clinical Research, Merz Investigational Site #0010522 accredited by Crixeo Health?

Quality Clinical Research, Merz Investigational Site #0010522 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Quality Clinical Research, Merz Investigational Site #0010522?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.